BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15104267)

  • 1. [A major vascular risk factor: mild impairment of renal function].
    Tepel M
    MMW Fortschr Med; 2003 Apr; 145(15):51-2. PubMed ID: 15104267
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease and global cardiovascular risk in essential hypertension.
    Segura J; Campo C; Ruilope LM
    Minerva Med; 2004 Oct; 95(5):375-83. PubMed ID: 15467513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.
    Astor BC; Hallan SI; Miller ER; Yeung E; Coresh J
    Am J Epidemiol; 2008 May; 167(10):1226-34. PubMed ID: 18385206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    Ruilope LM; Zanchetti A; Julius S; McInnes GT; Segura J; Stolt P; Hua TA; Weber MA; Jamerson K;
    J Hypertens; 2007 Jul; 25(7):1473-9. PubMed ID: 17563571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
    Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk.
    Segura J; Ruilope LM
    Fundam Clin Pharmacol; 2005 Aug; 19(4):429-37. PubMed ID: 16011729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking interacts with sleep apnea to increase cardiovascular risk.
    Lavie L; Lavie P
    Sleep Med; 2008 Mar; 9(3):247-53. PubMed ID: 17513169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and mild renal insufficiency in essential hypertension.
    Perticone F; Maio R; Tripepi G; Zoccali C
    Circulation; 2004 Aug; 110(7):821-5. PubMed ID: 15289371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
    Paraskevas KI; Giannoukas AD; Mikhailidis DP
    Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of cardiovascular outcome by the estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    Maaravi Y; Bursztyn M; Stessman J
    J Hypertens; 2008 Jan; 26(1):154; author reply 154. PubMed ID: 18090555
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting.
    Zakeri R; Freemantle N; Barnett V; Lipkin GW; Bonser RS; Graham TR; Rooney SJ; Wilson IC; Cramb R; Keogh BE; Pagano D
    Circulation; 2005 Aug; 112(9 Suppl):I270-5. PubMed ID: 16159830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global risk stratification in primary hypertension: the role of the kidney.
    Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of renal dysfunction as a cardiovascular risk factor.
    Adamczak M; Ritz E
    Rocz Akad Med Bialymst; 2005; 50():50-3. PubMed ID: 16358939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.
    Hallan S; Astor B; Romundstad S; Aasarød K; Kvenild K; Coresh J
    Arch Intern Med; 2007 Dec; 167(22):2490-6. PubMed ID: 18071172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years.
    Van Biesen W; De Bacquer D; Verbeke F; Delanghe J; Lameire N; Vanholder R
    Eur Heart J; 2007 Feb; 28(4):478-83. PubMed ID: 17223665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.